Evidence map›Paper›PMID 24818992›Full record

ArticlePloS one2014

Short term feeding of a high fat diet exerts an additive effect on hepatocellular damage and steatosis in liver-specific PTEN knockout mice.

Colin T Shearn, Kelly E Mercer, David J Orlicky, Leah Hennings, Rebecca L Smathers-McCullough, Bangyan L Stiles, Martin J J Ronis, Dennis R Petersen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 28 citations in OpenAlex.

  1. Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. PTEN: Tumor Suppressor and Metabolic Regulator.Frontiers in endocrinology · 2018
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Colin T ShearnDepartment of Pharmaceutical Sciences, University of Colorado Denver Anchutz Medical Campus, Aurora, Colorado, United States of America.
Kelly E MercerArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
David J OrlickyDepartment of Pathology, University of Colorado Denver Anchutz Medical Campus, Aurora, Colorado, United States of America.
Leah HenningsArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Rebecca L Smathers-McCulloughDepartment of Pathobiology, Cleveland Clinic, Cleveland, Ohio, United States of America.
Bangyan L StilesDepartment of Pharmaceutical Sciences, University of Southern California, Los Angeles, California, United States of America.
Martin J J RonisArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America; Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States of America.
Dennis R PetersenDepartment of Pharmaceutical Sciences, University of Colorado Denver Anchutz Medical Campus, Aurora, Colorado, United States of America.
University of Arkansas for Medical Sciences · USUniversity of Colorado Denver · USCleveland Clinic · USUniversity of Southern California · US

Funding

Lipid Aldehyde and Ethanol Induced Liver DamageR37AA009300 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI PETERSEN, DENNIS · 2008 to 2017
$4.4M
The role of PTEN and AKT2 in the malignant transformation of liver progenitor celR01CA154986 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI STILES, BANGYAN · 2013 to 2017
$1.7M
Proteomic profiling of NASH: disease mechanisms and novel treatmentR01DK074487 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PETERSEN, DENNIS · 2007 to 2011
$1.5M
Regulation of PTEN in chronic alcohol mediated liver diseaseF32AA018613 · NIAAA · UNIVERSITY OF COLORADO DENVER · PI SHEARN, COLIN · 2010 to 2012
$177k
NCI NIH HHS R01 CA154986NIAAA NIH HHS 5F32AA018613-03NIAAA NIH HHS 5R37AA009300-18 DRPNIAAA NIH HHS F32 AA018613NIAAA NIH HHS R37 AA009300NIDDK NIH HHS 5R01DK074487-06NIDDK NIH HHS R01 DK074487
6 · The paper itself

Abstract

backgroundHepatospecific deletion of PTEN results in constitutive activation of Akt and increased lipogenesis. In mice, the addition of a high fat diet (HFD) downregulates lipogenesis. The aim of this study was to determine the effects of a HFD on hepatocellular damage induced by deletion of PTEN.

methods12 Week old male flox/flox hepatospecific PTEN mice (PTENf/f) or Alb-Cre controls were fed a HFD composed of 45% fat-derived calories (from corn oil) or a normal chow. Animals were then analyzed for hepatocellular damage, oxidative stress and expression of enzymes involved in fatty acid metabolism.

resultsIn the Alb-Cre animals, the addition of a HFD resulted in a significant increase in liver triglycerides and altered REDOX capacity as evidenced by increased GPX activity, decreased GST activity and decreased hepatic concentrations of GSSG. In addition, SCD2, ACLY and FASN were all downregulated by the addition of HFD. Furthermore, expression of PPARα and PPARα-dependent proteins Cyp4a and ACSL1 were upregulated. In the PTENf/f mice, HFD resulted in significant increased in ALT, serum triglycerides and decreased REDOX capacity. Although expression of fatty acid synthetic enzymes was elevated in the chow fed PTENf/f group, the addition of HFD resulted in SCD2, ACLY and FASN downregulation. Compared to the Alb-Cre HFD group, expression of PGC1α, PPARα and its downstream targets ACSL and Cyp4a were upregulated in PTENf/f mice.

conclusionsThese data suggest that during conditions of constitutive Akt activation and increased steatosis, the addition of a HFD enhances hepatocellular damage due to increased CD36 expression and altered REDOX status. In addition, this work indicates HFD-induced hepatocellular damage occurs in part, independently of Akt signaling.

Indexed as

AnimalsCD36 AntigensCytochrome P-450 CYP4ADiet, High-FatFatty LiverLiverMaleMiceMice, KnockoutOxidative StressPTEN PhosphohydrolaseCD36 AntigensCytochrome P-450 CYP4APTEN Phosphohydrolase

Identifiers

PMID24818992
PMCPMC4018288
OpenAlexW2040611369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.